Innovative strategies to reduce HIV infections in East Africa
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
This study is looking for better ways to prevent and treat HIV in East Africa, especially for groups that are most affected, so that people can get personalized care right in their communities, like at family planning centers and youth hubs, with the aim of lowering new infections to almost zero.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11063789 on NIH RePORTER |
What this research studies
This research focuses on developing and testing new methods to prevent and treat HIV in East Africa, particularly targeting populations that contribute to ongoing infections. It involves two phases: the first phase will optimize prevention and treatment strategies through randomized controlled trials, while the second phase will implement a multi-sector intervention to enhance access to these services. Patients will benefit from tailored HIV prevention and treatment options that are integrated into community services, such as family planning and youth hubs. The goal is to significantly reduce new HIV infections to less than 0.1%.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in East Africa who are at high risk for HIV, such as youth, men, mobile populations, and heavy drinkers.
Not a fit: Patients who are not located in East Africa or who do not fall into the targeted high-risk categories may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a substantial decrease in new HIV infections and improved health outcomes for at-risk populations.
How similar studies have performed: Previous research has shown success with similar multi-sectoral approaches in addressing HIV prevention and treatment, indicating a promising potential for this innovative strategy.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Havlir, Diane V — University of California, San Francisco
- Study coordinator: Havlir, Diane V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.